Barry Vogel
Directeur/Membre du Conseil chez 180323 Canada, Inc.
Profil
Barry Vogel is currently a Director at 180323 Canada, Inc. He was previously a Director at Artes Medical, Inc. from 2008 to 2013.
Postes actifs de Barry Vogel
| Sociétés | Poste | Début |
|---|---|---|
180323 Canada, Inc.
 180323 Canada, Inc. Household/Personal CareConsumer Non-Durables 180323 Canada, Inc. develops and markets cosmetics and skin care products. Its products include Artecoll, Alyria, Betacaine, Cliniderm, Lipsorex, NeoStrata, Rosacure, and Ultraquin, as well as Condyline Topical Solution, Dermagran II, Epi-Derm and UltraMOP. The company was founded in 1972 and is headquartered in Saint-Laurent, Canada. | Directeur/Membre du Conseil | - |
Anciens postes connus de Barry Vogel
| Sociétés | Poste | Fin |
|---|---|---|
Artes Medical, Inc.
 Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 02/07/2013 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Artes Medical, Inc.
Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | Finance |
180323 Canada, Inc.
180323 Canada, Inc. Household/Personal CareConsumer Non-Durables 180323 Canada, Inc. develops and markets cosmetics and skin care products. Its products include Artecoll, Alyria, Betacaine, Cliniderm, Lipsorex, NeoStrata, Rosacure, and Ultraquin, as well as Condyline Topical Solution, Dermagran II, Epi-Derm and UltraMOP. The company was founded in 1972 and is headquartered in Saint-Laurent, Canada. | Consumer Non-Durables |
